✦ LIBER ✦

Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy—findings from clinical practice

✍ Scribed by Krzemieniecki, K.; Sevelda, P.; Erdkamp, F.; Smakal, M.; Schwenkglenks, M.; Puertas, J.; Trojan, A.; Szabo, Z.; Bendall, K.; Maenpaa, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Granulocyte-macrophage colony-stimulatin

✍ C.N Baxevanis; N.B Tsavaris; S.I Papadhimitriou; I.K Zarkadis; N.G Papadopoulos; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 804 KB

EORTC guidelines for the use of granuloc

✍ M.S. Aapro; D.A. Cameron; R. Pettengell; J. Bohlius; J. Crawford; M. Ellis; N. K 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 309 KB

Impact of Primary Prophylaxis With Granu

✍ Kuderer, N. M.; Dale, D. C.; Crawford, J.; Lyman, G. H. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 236 KB

2010 update of EORTC guidelines for the

✍ M.S. Aapro; J. Bohlius; D.A. Cameron; Lissandra Dal Lago; J. Peter Donnelly; N. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 523 KB